Modified platelet deposition on matrix metalloproteinase 13 digested collagen I

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 12, 2015, Pages 2253-2259

  Howes, J M ^a   Pugh, N ^b   Knauper V ^c   Farndale, R W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Collagen; Collagenase; GPVI collagen receptor; Matrix metalloproteinase 13; Platelets

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE 3; GLYCOPROTEIN VI; INTEGRIN; MMP13 PROTEIN, HUMAN; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; BLOOD CLOTTING; BLOOD FLOW; COLLAGEN DEGRADATION; CONTROLLED STUDY; ELECTROPHORESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ADHESION; BLOOD; ENZYMOLOGY; HUMAN; METABOLISM; THROMBOCYTE; THROMBOSIS;

BLOOD PLATELETS; COLLAGEN TYPE I; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; INTEGRIN ALPHA2BETA1; MATRIX METALLOPROTEINASE 13; PLATELET ADHESIVENESS; PROTEOLYSIS; THROMBOSIS;

EID: 84958780998     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13166     Document Type: Article

References (25)

1. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Hem 2004; 2: 561-73.
2. Ruggeri ZM, Mendolicchio GL. Interaction of von Willebrand factor with platelets and the vessel wall. Hamostaseologie 2015; 35: 211-24.
3. Adiguzel E, Ahmad PJ, Franco C, Bende MP. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009; 14: 73-89.
4. Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, Nagase H. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J 2004; 23: 3020-30.
5. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99: 2503-9.
6. Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008; 263: 517-27.
7. 2+-dependent binding of collagen by the integrin alpha2beta1 in human platelets. J Biol Chem 2000; 275: 24560-4.
8. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 2000; 275: 35-40.
9. Smethurst PA, Joutsi-Korhonen L, O'Connor MN, Wilson E, Jennings NS, Garner SF, Zhang Y, Knight CG, Dafforn TR, Buckle A, IJsseldijk MJ, De Groot PG, Watkins NA, Farndale RW, Ouwehand WH. Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 2004; 103: 903-11.
10. Pugh N, Simpson AM, Smethurst PA, de Groot PG, Raynal N, Farndale RW. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 2010; 115: 5069-79.
11. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544-50.
12. Messent AJ, Tuckwell DS, Knauper V, Humphries MJ, Murphy G, Gavrilovic J. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. J Cell Sci 1998; 111: 1127-35.
13. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272: 7608-16.
14. Lauer-Fields JL, Chalmers MJ, Busby SA, Minond D, Griffin PR, Fields GB. Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity. J Biol Chem 2009; 284: 24017-24.
15. Salsas-Escat R, Stultz CM. Conformational selection and collagenolysis in type III collagen. Proteins 2010; 78: 325-35.
16. Salsas-Escat R, Nerenberg PS, Stultz CM. Cleavage site specificity and conformational selection in type I collagen degradation. Biochemistry 2010; 49: 4147-58.
17. Howes JM, Bihan D, Slatter DA, Hamaia SW, Packman LC, Knauper V, Visse R, Farndale RW. The Recognition of Collagen and Triple-helical Toolkit Peptides by MMP-13: sequence specificity for binding and cleavage. J Biol Chem 2014; 289: 24091-101.
18. Siljander PR, Hamaia S, Peachey AR, Slatter DA, Smethurst PA, Ouwehand WH, Knight CG, Farndale RW. Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem 2004; 279: 47763-72.
19. Jung SM, Tsuji K, Moroi M. Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: direct evidence obtained with dimeric GPVI-specific Fabs. J Thromb Haemost 2009; 7: 1347-55.
20. Reininger AJ. VWF attributes-impact on thrombus formation. Thromb Res 2008; 122(Suppl. 4): S9-13.
21. Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res 2006; 120(Suppl. 1): S5-9.
22. O'Farrell TJ, Guo R, Hasegawa H, Pourmotabbed T. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule. Biochemistry 2006; 45: 15411-8.
23. Perumal S, Antipova O, Orgel JP. Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci USA 2008; 105: 2824-9.
24. Lemaitre V, Jungbluth A, Eeckhout Y. The recombinant catalytic domain of mouse collagenase-3 depolymerizes type I collagen by cleaving its aminotelopeptides. Biochem Biophys Res Commun 1997; 230: 202-5.
25. Herr AB, Farndale RW. Structural insights into the interactions between platelet receptors and fibrillar collagen. J Biol Chem 2009; 284: 19781-5.